Next Article in Journal
Administration of Nirsevimab for RSV Prophylaxis in Infants: A Comprehensive Review
Previous Article in Journal
The Safety and Immunogenicity of a Quadrivalent Influenza Subunit Vaccine in Healthy Children Aged 6–35 Months: A Randomized, Blinded and Positive-Controlled Phase III Clinical Trial
 
 
Article

Article Versions Notes

Vaccines 2025, 13(5), 468; https://doi.org/10.3390/vaccines13050468
Action Date Notes Link
article xml file uploaded 27 April 2025 09:26 CEST Original file -
article xml uploaded. 27 April 2025 09:26 CEST Update https://www.mdpi.com/2076-393X/13/5/468/xml
article pdf uploaded. 27 April 2025 09:26 CEST Version of Record https://www.mdpi.com/2076-393X/13/5/468/pdf
article supplementary file uploaded. 27 April 2025 09:26 CEST - https://www.mdpi.com/2076-393X/13/5/468#supplementary
article html file updated 27 April 2025 09:29 CEST Original file https://www.mdpi.com/2076-393X/13/5/468/html
Back to TopTop